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Granulocytic Ehrlichia was isolated from canine blood obtained from animals challenged with field-collected
Ixodes scapularis and propagated in HL60 cells. PCR primers specific for the 16S ribosomal DNA (rDNA) of
the Ehrlichia genogroup comprising E. equi, E. phagocytophila, and the agent of human granulocytic ehrlichiosis
(HGE) amplified DNA from extracts of these cells. Sequence analysis of this amplified DNA revealed that it is
identical to the 16S rDNA sequence of the HGE agent. A genomic library was constructed with DNA from
granulocytic Ehrlichia and screened with pooled sera from tick-challenged, granulocytic Ehrlichia-infected
dogs. Several clones were isolated and sequenced. Three complete genes encoding proteins with apparent
molecular masses of 100, 130, and 160 kDa were found. The recombinant proteins reacted with convalescent-
phase sera from dogs and human patients recovering from HGE. This approach will be useful for identifying
candidate diagnostic and vaccine antigens for granulocytic ehrlichiosis and aid in the classification of geno-
group members.
Members of the genus Ehrlichia include species which have
a tropism for mononuclear phagocytes (E. canis, E. chaffeensis,
E. muris, E. sennetsu, and E. risticii) (33) and those which infect
granulocytes (E. ewingii [33], E. phagocytophila [10, 33], E. equi
[14, 26], and the recently discovered agent of human granulo-
cytic ehrlichiosis [HGE] [3, 7]). Disease caused by granulocytic
Ehrlichia (GE) is manifested by fever, lethargy, thrombocyto-
penia, and death, and many species from diverse geographical
locations have shown evidence of natural infection, including
horses (25, 27, 29, 38), dogs (24, 34, 35), small mammals (39,
40), and humans (4, 15).
The similar host range and near identity of the 16S rRNA
genes of E. phagocytophila, E. equi, and the HGE agent (7)
have raised the possibility that these organisms represent a
single species (2, 28). In addition, Dumler et al. (9) have shown
that they share significant antigenicity by immunofluorescence
and immunoblot assays. Objective methods for species classi-
fication, e.g., molecular genetic analysis, have not been readily
available, primarily because of an inability to culture these
ehrlichiae in vitro. However, we (reference 43 and unpublished
data) and others (13) have recently demonstrated successful
cultivation of GE isolates from dogs and humans, respectively.
In this paper, we describe the use of purified GE obtained
from in vitro culture of infected HL60 cells, a promyelocytic
human cell line, to generate a genomic DNA library for ex-
pression screening with sera obtained from dogs experimen-
tally infected with GE. The screening resulted in the isolation
of recombinant clones containing complete genes encoding
three putative proteins of GE, GE 160, GE 130, and GE 100
(named for apparent molecular mass in kilodaltons). One of
these proteins, the 100-kDa protein, is similar in both glutamic
acid content and repeated amino acid structure to an immu-
nodominant 120-kDa E. chaffeensis protein (45). Both the 100-
and 130-kDa granulocytic Ehrlichia proteins share some amino
acid sequence homology to the 120-kDa E. chaffeensis protein.
MATERIALS AND METHODS
Isolation of GE in cell culture. The GE agent (strain USG3) was isolated as
described previously (43). Briefly, blood from a dog experimentally infected by
adult Ixodes scapularis ticks collected from both Westchester County, N.Y., and
Montgomery County, Pa., was inoculated into a suspension culture of the human
promyelocytic cell line HL60 (ATCC CCL 240). The cells were cultured in RPMI
1640 medium supplemented with 20% heat-inactivated fetal bovine serum, 2 mM
L-glutamine, 1 mM sodium pyruvate, and 0.1 mM nonessential amino acids and
maintained at 37°C and 6% CO2 in a humidified chamber. The fetal bovine
serum was reduced to 10% once the culture was established. Ehrlichial infection
was indicated by lysis of the HL60 cells. Cultures of USG3 (passages 7 to 21)
were grown for 5 days prior to GE purification.
Purification of GE. USG3 cultures at approximately 80% cell lysis (monitored
microscopically) were centrifuged at 840 3 g for 15 min at 4°C to remove host
HL60 cell debris. The supernatant was filtered through a Poretics (Livermore,
Calif.) 5-mm-pore-diameter polycarbonate membrane, 47 mm in diameter, fol-
lowed by a Poretics 3-mm-pore-diameter filter under negative pressure. The
USG3 filtrate was centrifuged at 9460 3 g in a Sorvall centrifuge for 30 min at
4°C. Following centrifugation, the GE pellet was resuspended in 5 ml of 25 mM
Tris (pH 8.0)–10 mM MgCl2–0.9% NaCl. DNase I (Life Technologies, Gaith-
ersburg, Md.) was added to a final concentration of 9 mg per ml, and the solution
was incubated for 15 min at 37°C. Following incubation, the DNase was inacti-
vated by the addition of 0.5 ml of 0.5 M EDTA, and the GE was pelleted at
14,000 3 g in a Sorvall centrifuge for 30 min at 4°C.
PCR amplification and cloning of GE 16S ribosomal DNA. Universal eubac-
terial primers for the 16S rRNA gene (41) were modified to include restriction
enzyme recognition sites as follows: forward primer, 59 CTGCAGGTTTGATC
CTGG 39 (PstI site); reverse primer, 59 GGATCCTACCTTGTTACGACTT 39
(BamHI site). These primers (0.5 mM) were added to a 100-ml reaction mixture
containing 13 PCR buffer II (Perkin-Elmer Corp.); 1.5 mM MgCl2 (Perkin-
Elmer Corp.); 200 mM (each) dATP, dGTP, dCTP, and dTTP; 2.5 U of Amplitaq
DNA polymerase; and 20 ml of USG3 DNA. Amplification was performed under
the following conditions: 35 cycles at 94°C for 1 min, 53°C for 1 min, and 72°C for
2 min, followed by a 72°C incubation for 10 min. The amplified 1,500-bp frag-
ment was digested with PstI and BamHI and ligated to pUC19 linearized with the
same enzymes. The resulting clone, pUCHGE16S, was sequenced as described
below.
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Construction of a GE genomic library. Genomic DNA was isolated from
purified GE with the QIAamp Genomic DNA kit (Qiagen, Chatsworth, Calif.)
for library preparation (Stratagene, La Jolla, Calif.). The DNA was mechanically
sheared to a 4- to 10-kb size range and ligated to EcoRI linkers. Linkered
fragments were ligated into the EcoRI site of Lambda Zap II, and the library was
amplified in Escherichia coli XL1-Blue MRF9 to a titer of 1010 PFU/ml.
Expression screening of the genomic library. Bacteriophage were plated with
XL1-Blue MRF9 and induced to express protein with 10 mM isopropyl-b-D-
thiogalactopyranoside (IPTG) (Sigma, St. Louis, Mo.). Proteins were transferred
to nitrocellulose filters, and the filters were washed with Tris-buffered saline
(TBS; 25 mM Tris HCl [pH 7.5], 0.5 M NaCl). Washed filters were blocked in
TBS containing 0.1% polyoxyethylene 20 cetyl ether (Brij 58) and incubated with
a 1:50 dilution of pooled sera (depleted of anti-E. coli antibodies) taken from
four dogs experimentally infected by exposure to field-collected adult I. scapu-
laris ticks (8). The filters were washed and incubated with rabbit anti-dog horse-
radish peroxidase-conjugated immunoglobulin (Ig) antibody, rewashed, and de-
veloped with 4-chloronaphthol. Positive plaques were isolated, replated, and
screened again. Plasmid DNA containing the putative recombinant clones was
obtained by plasmid rescue (Stratagene).
DNA sequencing and sequence analysis. DNA sequencing of recombinant
clones was performed by the primer walking method and with an ABI 373A
DNA sequencer (ACGT, Northbrook, Ill.; Lark Technologies, Houston, Tex.;
and Sequegen, Shrewsbury, Mass.). Sequences were analyzed by the MacVector
(Oxford Molecular Group) sequence analysis program, version 6.0. The BLAST
algorithm, D version 1.4 (19, 20), was used to search for homologous nucleic acid
and protein sequences available on the National Center for Biotechnology In-
formation (NCBI) server.
PCR analysis of USG3 and HL60 DNA. PCR primer sets were designed based
on the sequences of each of the three GE clones and are as follows: S2 (forward,
59-GCGTCTCCAGAACCAG-39; reverse, 59-CCTATATAGCTTACCG-39), S7
(forward, 59-GATGTTGCTTCGGGTATGC-39; reverse, 59-CAGAGATTACT
TCTTTTTGCGG-39), and S22 (forward, 59-CACGCCTTCTTCTAC-39; reverse,
59-CTCTGTTGCTATAGGGGC-39). Each 50-ml reaction mixture contained 0.5
mM each primer, 13 PCR Supermix (Life Technologies, Gaithersburg, Md.) and
either 100 ng of USG3 DNA, 100 ng of HL60 DNA, or 200 ng of plasmid DNA.
PCR amplification was performed under the following conditions: 94°C for 30 s,
55°C for 30 s, and 72°C for 1 min. After 30 cycles, a single 10-min extension at
72°C was done. PCR products were analyzed on 4% Nusieve 3:1 agarose gels
(FMC Bioproducts, Rockland, Me.).
Western blot analysis. Individual recombinant plasmid-containing cultures
were induced to express protein with 5 mM IPTG. Bacterial cells were pelleted
by centrifugation and resuspended in 53 Laemmli buffer (12% glycerol, 0.2 M
Tris-HCl [pH 6.8], 5% sodium dodecyl sulfate [SDS], 5% b-mercaptoethanol) at
200 ml per optical density unit of culture. Samples were boiled for 5 min, and 10
ml of each was analyzed by SDS-polyacrylamide gel electrophoresis (PAGE) (for
dog sera) or NuPage (Novex, San Diego, Calif.) electrophoresis (for human
sera). Proteins were transferred to nitrocellulose filters, the filters were blocked
in TBS-Brij 58, and the blots were probed with either the pooled dog sera
referenced above or 1:1,000 dilutions of human sera. The sera used in this study
were two convalescent-phase serum samples from patients (no. 2 and 3 from New
York, kindly provided by M. Aguero-Rosenfeld) and one sample from an indi-
vidual in Wisconsin who was part of a seroprevalence study (no. 1, kindly
provided by J. Bakken). Blots were washed and incubated with biotin-labeled
goat anti-dog IgG (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.)
followed by peroxidase-labeled streptavidin (Kirkegaard & Perry Laboratories,
Inc.) or horseradish peroxidase-conjugated antihuman IgG (Bio-Rad, Hercules,
Calif.). After several additional washes, the dog serum blots were developed with
4-chloronaphthol (Bio-Rad), and the human serum blots were detected by en-
hanced chemiluminescence (Pierce, Rockford, Ill.) and viewed by autoradiogra-
phy.
Nucleotide sequence accession number. The nucleotide sequences of the GE
genes described here have been assigned the following GenBank accession num-
bers: ank (GE 160), AF020521; rea (GE 130), AF020522; and gra (GE 100),
AF020523.
RESULTS
Cloning and sequencing of the USG3 16S rRNA gene.
Sources of GE used to generate a cell culture isolate have
included blood from either infected humans (13) or dogs (32,
43). To assess the relatedness of the USG3 isolate to other GE
isolates, including the HGE agent, the 16S rRNA gene was
amplified by PCR with universal eubacterial primers (41). A
1,500-bp DNA fragment was isolated and cloned into pUC19
(see Materials and Methods), and the insert DNA was se-
quenced. The USG3 16S rRNA gene sequence was found to be
identical to the GenBank sequence of the HGE agent (acces-
sion no. U02521). The sequences of other 16S ribosomal DNA
PCR fragments generated with USG3 DNA as the template
were also identical to the HGE agent sequence (reference 43
and data not shown).
Isolation of recombinant clones identified with GE-positive
dog sera. Using pooled sera from adult I. scapularis-chal-
lenged, GE-infected dogs, positive clones were identified and
purified as single plaques. pBluescript plasmids were rescued
according to the Stratagene protocol, and DNA was purified
with Qiagen plasmid purification kits. A number of restriction
digests were performed with each clone to assess their relat-
edness (data not shown). Based on these digests, restriction
maps were generated which showed that all of the clones
represented just three different GE genes. One clone from
each of the three gene groups (clones S2, S7, and S22) was
chosen for further analysis.
Analysis of proteins encoded by GE clones. Because recom-
binant clones were selected based on immunoreactivity, bac-
terial lysates of each clone were analyzed by SDS-PAGE and
Western blotting to identify the immunoreactive proteins. The
blots were probed with the same pooled canine sera used to
screen the library. Figure 1A shows the reactivity of the anti-
sera against purified USG3. Several immunodominant proteins
with sizes of 36, 43, and 45 kDa were observed, and other
less-immunoreactive proteins of various molecular masses are
FIG. 1. Expression of GE proteins by Western blotting. (A) Purified USG3
disrupted in SDS (lane GE). (B) Individual recombinant clones containing the
genes coding for GE 100, GE 160, GE 130, and a negative control (NEG [no
insert]) were grown and incubated with IPTG to induce protein expression as
described in Materials and Methods. Samples of each were electrophoresed on
SDS-PAGE gels and transferred to nitrocellulose for Western blotting. Blots
were probed with convalescent-phase dog sera. Molecular mass markers (M) (in
kilodaltons) are shown to the left of each panel.
FIG. 2. Expression of GE proteins by Western blotting. Three different hu-
man serum samples were used to probe Western blots containing SDS-disrupted
USG3 (GE lanes), GE 160, GE 100, and GE 130. A pBluescript library clone
containing no insert was used as a negative control (NEG). The origin of the sera
is indicated at the bottom of each panel (WI, Wis.; NY, N.Y.). Molecular mass
markers (in kilodaltons) are shown to the left of each panel.











shown. Figure 1B shows the Western blot of the library clones,
S2, S7, and S22. A single high-molecular-mass protein (indi-
cated by arrows) was detected by the sera for each isolated
clone. These proteins were not expressed in the absence of
IPTG induction and were not detected with preimmune dog
sera (data not shown). The approximate molecular masses of
each protein are as follows: 160 (S2), 100 (S7), and 130 (S22)
kDa. These proteins are not the major immunodominant an-
tigens of the purified cell culture isolate USG3, two of which
migrate at about 43 to 45 kDa (Fig. 1A), but they could be
present among the higher-molecular-mass immunoreactive
proteins.
The three GE proteins were also analyzed by Western blot-
ting for their reactivity with human sera. Figure 2 shows three
different human serum samples tested against purified USG3
antigen and the three GE recombinant proteins. Each serum
sample reacted strongly with one of the three GE proteins: no.
1 with GE 160 and less strongly with GE 130, no. 2 with GE
100, and no. 3 with GE 130. All three serum samples reacted
with several proteins in the purified USG3 lanes (GE lanes). A
FIG. 3. Sequence of the 160-kDa protein gene. Nucleotide numbers are
indicated to the left. The ATG start codon and TAA stop codon are shown in
boldface type. The translated amino acid sequence for the open reading frame is
displayed underneath the DNA sequence according to the single-letter amino
acid code. Upstream regulatory sequences are underlined and represent the
235, 210, and ribosome binding sites.
FIG. 4. Sequence of the 100-kDa protein gene. Nucleotide numbers are
indicated to the left. The ATG start codon and TAA stop codon are shown in
boldface type. The translated amino acid sequence for the open reading frame is
displayed underneath the DNA sequence according to the single-letter amino
acid code. A possible ribosome binding site is underlined.











serum sample from a Rhode Island HGE patient recognized
two of the three GE proteins, and other HGE patient sera
tested also recognized one or two of the proteins (data not
shown). None of the samples we have tested to date react
strongly with all three recombinant GE proteins. Negative con-
trol human sera did not react with the GE proteins on Western
blots (data not shown).
It is interesting to note that these human sera do not strongly
recognize proteins with sizes of 100, 130, and 160 kDa with
USG3 lysates as the antigen source. This may be due to un-
derrepresentation of these proteins in the purified cell culture
antigen, either because they are secreted or because they are
expressed only after infection of a host species.
DNA sequencing and database analysis of recombinant
clones. The inserts from each of the recombinant plasmids S2,
S7, and S22 were completely sequenced by the primer walking
method. Sequence analysis (MacVector 6.0; Oxford Molecular
Group) showed that each clone contained a single large open
reading frame encoded by the plus strand of the insert and that
each one appeared to be a complete gene. The portions of the
DNA sequence containing the open reading frame and corre-
sponding amino acid sequence of each of the clones are shown
as follows: Fig. 3, S2, GE 160; Fig. 4, S7, GE 100; and Fig. 5,
S22, GE 130. A possible ribosome binding site sequence up-
stream from the initiating ATG codon is underlined in each
figure.
The numbers of nucleotides sequenced upstream of each
reading frame were 1,500 bp for the S2 insert, 500 bp for the
S22 insert, and 200 bp for the S7 insert. These sequences were
examined for likely ehrlichial promoter sequences based on
homology to the E. coli 235 and 210 consensus sequences
(16). Of the three clones, S2 had the closest homology to the E.
coli promoter sequences, and these are underlined in Fig. 3. A
number of possible promoter sequences were found for the
S22 and S7 genes, but in the absence of direct experimental
evidence, it is difficult to determine which sequence elements
are necessary for promoter function. Protein expression in all
three clones was IPTG dependent, and thus it is likely that the
vector lacZ promoter is used for transcription of the Ehrlichia
RNA in E. coli.
Amino acid sequence analysis of the proteins encoded by the
three gene clones showed that all contain regions of repeated
amino acids. A schematic version of these repeat structures is
shown in Fig. 6 and 7. The 160-kDa protein (Fig. 6) has three
groups of repeats. The first set consists of a number of ankyrin-
like repeat units of 33 amino acids, the second consists of
repeat units of 27 amino acids, and the third consists of repeat
units of 11 amino acids. The ankyrin repeats were revealed by
a BLAST database search for protein homologies. Ankyrin
repeats occur in at least four consecutive copies and are
present in yeast, plants, bacteria, and mammals (5, 6). Figure 6
shows a multiple alignment of the 160-kDa protein ankyrin
repeats under a consensus sequence derived from the analysis
FIG. 5. Sequence of the 130-kDa protein gene. Nucleotide numbers are
indicated to the left. The ATG start codon and TAA stop codon are shown in
boldface type. The translated amino acid sequence for the open reading frame is
displayed underneath the DNA sequence according to the single-letter amino
acid code. A possible ribosome binding site is underlined.
FIG. 6. Schematic diagram of the GE 160-kDa protein. Repeat regions are
indicated by the boxes. Sequences of proposed ankyrin repeats, numbered 1 to 8,
are aligned according to the consensus sequence at the top (6). h, hydrophobic;
t, turn-like or polar; S/T, serine or threonine; capital letters, conserved amino
acids.











of several hundred similar ankyrin-like motifs (6). The eighth
repeat sequence holds to the consensus only through the first
half of the repeat unit and may not represent a full ankyrin-like
repeat.
The 130-kDa protein (Fig. 7) has a repeat unit of 26 to 34
amino acids which occurs eight times in the carboxy-terminal
half of the protein. The sequence varies somewhat from repeat
to repeat. A database homology search with the NCBI BLAST
algorithm revealed that the 130-kDa protein has limited ho-
mology to the E. chaffeensis 120-kDa protein (45). An amino
acid sequence alignment of a motif common to both proteins is
shown in Fig. 7A. This motif is represented by a bold line and
occurs four times in an identical fashion in the E. chaffeensis
protein (designated A-1) and eight times with four variations
in the GE 130-kDa protein (a-1, a-2, a-3, and a-4).
The 100-kDa protein (Fig. 7) has three large repeat units,
which differ somewhat in length. A database search revealed
that it is similar to the 120-kDa E. chaffeensis protein, which
contains four repeats of 80 amino acids each (45). Both pro-
teins contain large amounts of glutamic acid: 18% for the
100-kDa protein and 17% for the 120-kDa protein. When the
two protein sequences are aligned, most of the homology oc-
curs in the repeat regions. Figure 7B shows alignments for two
homologous groups of amino acid motifs from the two proteins
(designated B/b and C/c) found with the BLAST algorithm.
These are not the only possible alignments of the two proteins
but do provide an example of their similarities. The locations
of the homologous sequences are indicated by bold or hatched
lines above (GE 100) or below (E. chaffeensis 120) the respec-
tive proteins. The B sequence represented by the bold line
varies slightly in the E. chaffeensis protein (shown as B-1, B-2,
and B-3) and occurs a total of five times. The GE 100 protein
equivalent, b-1, is invariant and occurs three times. The se-
quence represented by the hatched line occurs four times in E.
chaffeensis 120 (C-1) and two times in GE 100 (c-1).
All of the GE proteins migrated at higher apparent molec-
ular masses under reducing conditions than calculations would
predict. The GE 160 protein consists of 748 amino acids with
a calculated molecular mass of 78.8 kDa. The GE 100 protein
has 578 amino acids, and its calculated molecular mass is 61.4
kDa. The GE 130 protein contains 619 amino acids and has a
calculated molecular mass of 66.1 kDa.
Verification that clones are GE derived with PCR analysis.
Based on the DNA sequences of each clone, PCR primers
were designed to amplify specific regions of each open reading
frame (see Materials and Methods). Primer pairs specific for
S22, S2, and S7 were used in separate PCRs to amplify three
different templates: GE DNA (from USG3), HL60 DNA, or
FIG. 7. Amino acid sequence alignments of selected regions of GE 130-kDa and E. chaffeensis 120-kDa proteins (A) and GE 100-kDa and E. chaffeensis 120-kDa
proteins (B). Each protein is shown as a linear amino acid sequence, and amino acids are numbered in hundreds. Boxed regions on the linear sequence represent
repeated amino acids. (A) Amino acid alignments of a sequence which occurs four times in the E. chaffeensis protein (45) (top line of alignment, A-1) and eight times
in the GE 130-kDa protein (a-1 to a-4). Sequence a-1 is repeated three times, related sequences a-2 and a-3 are each repeated twice, and related sequence a-4 is found
once. The positions of these sequences in the proteins are indicated by the small bold lines. (B) Alignments of two different sequence motifs which occur in the E.
chaffeensis 120-kDa protein (B-1 to B-3 and C-1) and the GE 100-kDa protein (b-1 and c-1). Bold and cross-hatched boxes indicate the positions of these sequences
in the proteins. Identical amino acids are surrounded by boxes, and conserved amino acids are in capital letters.











the purified plasmid DNA of each clone. Figure 8 shows the
results obtained for primers of S2 (lanes 2 to 4), S7 (lanes 5 to
7), and S22 (lanes 8 to 10). All three clones were specific to GE
and were not present in HL60 DNA (lanes 2, 5, and 8). In each
case, the size of the PCR product determined with genomic
DNA as the template was the same as that generated by the
purified plasmid DNA.
DISCUSSION
Ehrlichiae which have a tropism for peripheral blood gran-
ulocytes and are closely related based on the sequence of the
16S rRNA gene have been classified as either E. phagocyto-
phila, E. equi, or the agent of HGE, depending on the species
and geographical location of the infected host. E. phagocyto-
phila is responsible for a tick-borne fever of cattle, sheep, and
goats and occurs primarily in Europe (10, 33), and E. equi is
found in horses in North and South America (14, 26). The
agent of HGE has been identified as the organism responsible
for disease in patients in the upper midwestern and northeast-
ern United States (3, 7). However, classification of GE has
been difficult because of a lack of genetic information.
The GE isolate we describe here is indistinguishable from
the HGE agent based on the sequence of the 16S rRNA gene.
We also describe three previously unidentified proteins of GE,
the 160-, 130-, and 100-kDa proteins. Aside from the 16S
rRNA gene and the relatively conserved groEL homolog (22),
the genes coding for these proteins are the first sequenced
genes reported for this organism. Using PCR primers based on
the sequences of the three genes, we have confirmed that the
genes are specific for GE and that they are not derived from
the HL60 cell line used to culture the organism. Preliminary
results also show that these genes are present in other mem-
bers of the GE genogroup, including E. phagocytophila (31a).
The three GE proteins described in this study exhibit several
interesting features. All three of the proteins contain repeated
regions of amino acids. In the 100-kDa protein, the repeats
comprise the majority of the protein, with the exception of the
amino terminus. The direct repeats in both the 160- and 130-
kDa proteins occur in the carboxyl half of the molecules. Var-
ious biological functions have been demonstrated or impli-
cated for repeat regions found in other proteins. These include
antigenic variation (17, 31) and ligand interaction (11, 42),
both of which are thought to occur in several species of patho-
genic bacteria (42). In several proteins of the malaria parasite
Plasmodium falciparum, repeated regions are often the major
targets for the host antibody response (21). Proteins with sev-
eral repeated domains are also often found associated with the
cell surface (12, 42). In addition to the direct repeats, the
160-kDa protein contains seven to eight ankyrin-like repeats.
These domains have been found in over 90 different proteins
from nearly all phyla, including both E. coli and humans (6).
They are present in functionally diverse proteins, such as en-
zymes, toxins, and transcription factors, and are thought to
play a role in protein-protein interactions (5). Human eryth-
rocyte ankyrin contains 22 repeats, some of which may be
involved in binding tubulin, spectrin, or vimentin. The repeats
could thus enable the protein to act like a bridge between
cytoskeleton and membrane components (23). The myriad
functions ascribed to proteins containing repeated regions may
imply that the GE proteins described here will be found to
have roles in host cell binding, antigenic variation, or some
other cell surface function.
The presence of repeated regions in the 100-, 130-, and
160-kDa proteins may in part explain the differences between
the expected molecular masses and the observed molecular
masses on SDS-PAGE, which are much higher. This phenom-
enon has been reported for other proteins containing repeated
regions, including rickettsial proteins (1, 36), malaria antigens
(21), the fibronectin-binding protein from Staphylococcus au-
reus (18, 37), and the E. chaffeensis 120-kDa protein (45). The
difference between calculated and observed molecular mass
varies from 10 to 30% for the malaria antigens to almost 100%
for the S. aureus and E. chaffeensis proteins. Investigators have
speculated that high percentages of certain amino acids in
these proteins or posttranslational modifications may contrib-
ute to the aberrant migration in an SDS-polyacrylamide gel
system (18, 37, 45).
A search of the major protein and nucleotide databases with
the NCBI BLAST algorithm did not reveal any significant
similarities of the GE proteins to any known proteins, other
than the ankyrin repeats of the 160-kDa protein and the ho-
mology between the 100-kDa protein or 130-kDa protein and
the 120-kDa protein of E. chaffeensis. The function of the E.
chaffeensis 120-kDa protein is not known, but the hydrophilic
nature of its repeat domain suggests that it may be located on
the surface of E. chaffeensis (45). The GE 100-kDa protein is
also hydrophilic in the repeat region (data not shown) and may
also be surface associated. Although both the 100- and 130-
kDa proteins have some homology to the E. chaffeensis 120-
kDa protein, they are not homologous to one another. It is
possible that whatever the function(s) of the 120-kDa protein
is for E. chaffeensis, similar functions may be carried out in GE
through the proteins GE 100 and GE 130.
It is unclear whether the three GE proteins described in this
report may be useful as potential diagnostic reagents or vac-
cine candidates. Although they are not well represented in the
purified-culture-grown organism, either because they are se-
FIG. 8. PCR analysis of GE genes. PCRs were performed as described in
Materials and Methods, and the products were analyzed with 4% Nusieve gels.
S2 primers were used to amplify a 395-bp region of S2 DNA with HL60 DNA
(lane 2), S2 plasmid DNA (lane 3), and USG3 DNA (lane 4) used as templates.
S7 primers were used to amplify a 643-bp region of S7 DNA with HL60 DNA
(lane 5), S7 plasmid DNA (lane 6), and USG3 DNA (lane 7) used as templates.
S22 primers were used to amplify a 159-bp region of S22 DNA with HL60 DNA
(lane 8), S22 plasmid DNA (lane 9), and USG3 DNA (lane 10) used as tem-
plates. DNA molecular size markers (M) (50 to 1,000 bp [FMC, Rockland,
Maine]) are present in lane 1.











creted into the culture medium or their expression is tied more
closely to natural infection, they are clearly important immu-
nologically. All three react with convalescent-phase sera from
dogs, sheep (data not shown), and humans diagnosed with
HGE. The E. chaffeensis 120-kDa protein, the counterpart of
the 100-kDa GE protein, has shown sensitivity and specificity
as a diagnostic reagent with a panel of E. chaffeensis patient
sera (44). However, Western blots with convalescent-phase
sera from HGE patients do not show a consistent response to
the GE 100-kDa protein. It is not known whether there is any
immunologic cross-reactivity between the GE 100-kDa protein
and the E. chaffeensis 120-kDa protein or whether the two
could be used to distinguish monocytic from granulocytic ehr-
lichiosis. Some human antisera have been reported to react
with both E. chaffeensis and HGE antigens, but it is not known
whether this represents cross-reactive epitopes or separate ex-
posures to the two ehrlichial agents (30, 32).
In summary, the expression library approach for the isola-
tion and characterization of GE proteins has resulted in the
discovery of three previously unidentified genes which express
high-molecular-weight, immunoreactive proteins. Further
study of these proteins will aid in the classification of the
members of the GE genogroup as corresponding genes are
sequenced and compared and will be important in elucidating
the role of these proteins in immunity and pathogenesis.
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